Abeona Therapeutics Inc. (ABEO) is priced at $1.85 after the most recent trading session. At the very opening of the session, the stock price was $1.71 and reached a high price of $1.87, prior to closing the session it reached the value of $1.73. The stock touched a low price of $1.71.
Recently in News on June 2, 2021, Abeona Therapeutics to Present at Jefferies Virtual Healthcare Conference. Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that Michael Amoroso, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 10:30 a.m. ET. You can read further details here
Abeona Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.7899 on 02/09/21, with the lowest value was $1.2600 for the same time period, recorded on 05/11/21.
Abeona Therapeutics Inc. (ABEO) full year performance was -33.45%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Abeona Therapeutics Inc. shares are logging -51.19% during the 52-week period from high price, and 86.96% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.99 and $3.79.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1505294 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Abeona Therapeutics Inc. (ABEO) recorded performance in the market was 17.83%, having the revenues showcasing -18.14% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 197.27M, as it employees total of 76 workers.
Abeona Therapeutics Inc. (ABEO) in the eye of market guru’s
During the last month, 0 analysts gave the Abeona Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.9554, with a change in the price was noted -0.06. In a similar fashion, Abeona Therapeutics Inc. posted a movement of -3.14% for the period of last 100 days, recording 3,167,595 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ABEO is recording 0.02 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.01.
Abeona Therapeutics Inc. (ABEO): Stocks Technical analysis and Trends
Raw Stochastic average of Abeona Therapeutics Inc. in the period of last 50 days is set at 75.64%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 89.23%. In the last 20 days, the company’s Stochastic %K was 80.10% and its Stochastic %D was recorded 75.81%.
If we look into the earlier routines of Abeona Therapeutics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 17.83%. Additionally, trading for the stock in the period of the last six months notably improved by 20.92%, alongside a downfall of -33.45% for the period of the last 12 months. The shares increased approximately by 1.65% in the 7-day charts and went down by 41.22% in the period of the last 30 days. Common stock shares were lifted by -18.14% during last recorded quarter.